Wu, Chung-Pu
5780  Ergebnisse:
Personensuche X
?
1

ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibit..:

Wu, Chung-Pu ; Hung, Cheng-Yu ; Murakami, Megumi...
International Journal of Molecular Sciences.  25 (2024)  10 - p. 5160 , 2024
 
?
2

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhi..:

Wu, Chung-Pu ; Li, Yen-Ching ; Murakami, Megumi...
International Journal of Molecular Sciences.  24 (2023)  18 - p. 13972 , 2023
 
?
3

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Res..:

Li, Yen-Ching ; Hsiao, Sung-Han ; Murakami, Megumi...
ACS Pharmacology & Translational Science.  7 (2023)  1 - p. 161-175 , 2023
 
?
 
?
8

Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs i..:

Li, Yan-Qing ; Murakami, Megumi ; Huang, Yang-Hui...
International Journal of Molecular Sciences.  23 (2022)  21 - p. 12763 , 2022
 
?
9

The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0..:

Wu, Chung-Pu ; Hsieh, Ya-Ju ; Tseng, Han-Yu...
Biomedicine & Pharmacotherapy.  154 (2022)  - p. 113663 , 2022
 
?
11

Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhi..:

Wu, Chung-Pu ; Murakami, Megumi ; Wu, Yu-Shan...
Frontiers in Cell and Developmental Biology.  9 (2021)  - p. , 2021
 
?
13

Sophoraflavanone G Resensitizes ABCG2-Overexpressing Multid..:

Wu, Chung-Pu ; Li, Yan-Qing ; Hung, Tai-Ho...
Journal of Natural Products.  84 (2021)  9 - p. 2544-2553 , 2021
 
?
14

Overexpression of Human ABCB1 and ABCG2 Reduces the Suscept..:

Wu, Chung-Pu ; Hung, Cheng-Yu ; Lusvarghi, Sabrina...
International Journal of Molecular Sciences.  22 (2021)  5 - p. 2592 , 2021
 
1-15